Clinical trial
The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
NCT02650102 is registered in ClinicalTrials.gov with Shanxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Lead sponsor
- Shanxi Medical University
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 31, 2013
- Completion date
- December 31, 2016
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.